GSS 0.65% 77.0¢ genetic signatures limited

Ann: First quarter sales update, page-13

  1. 396 Posts.
    lightbulb Created with Sketch. 237
    Interesting to play around with some revenue assumptions:

    Assume 25% quarterly sequential growth - half the current growth rate - from here yields.

    Q1 2021 $10.5m
    Q2 $13.1m
    Q3 $16.4m
    Q4 $20.5m
    Full year revenue 2021 $60.5 million

    Assume a reduction down to 10%.
    Q1 2021 $10.5m
    Q2 $11.5m
    Q3 $12.7m
    Q4 $14.0m
    Full year revenue 2021 $48.7 million

    Based upon the organic growth currently on display, even without the sale of new products or untapped global markets, it looks likely that GSS is still very much at an early phase in its growth and that, subject to execution, it is well positioned to continue its revenue growth this year and beyond.

 
watchlist Created with Sketch. Add GSS (ASX) to my watchlist
(20min delay)
Last
77.0¢
Change
-0.005(0.65%)
Mkt cap ! $174.4M
Open High Low Value Volume
77.5¢ 78.0¢ 77.0¢ $11.23K 14.48K

Buyers (Bids)

No. Vol. Price($)
1 19491 76.0¢
 

Sellers (Offers)

Price($) Vol. No.
78.0¢ 162903 2
View Market Depth
Last trade - 15.45pm 19/07/2024 (20 minute delay) ?
GSS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.